Skip to content
Spin Online

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Deal Over Data Fears

Health funding image
The proposed US financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US health deal worth 367 million US dollars (£272m) spanning five years over the United States' demand for confidential biological samples.

This move became public following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government representative has since stated that the US was demanding access to genetic material for research and profit but was unwilling to guarantee the benefits from any future medical innovations.

"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged more talks to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can proceed.

Broader Background

This rejection comes after a similar situation in Kenya, where a court halted a related deal with the US following concerns were filed about the security of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to boost transparency and responsibility.

Based on statements, 16 nations in Africa have to date signed similar agreements, representing over $18.3bn in committed funds.

Specifics of the Declined Deal

This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," he stated.

"Effectively, our nation would supply the basic resources for medical research with no assurance that the end products would be accessible to our people should a future pandemic arise."

Sovereignty and Global Health

He also said that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending structures already set up via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This mechanism is designed to ensure that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."

The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We are open to continued dialogue with our US partners on how subsequent collaboration could be structured in a manner that respects the sovereignty and interests of both nations."

Health Experts Response

A leading public health body stated it understood the official position, but suggested that negotiations must proceed since a large portion of the country's Aids initiatives were funded by foreign aid.

"Where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group added.

The halted deal emphasises the continuing tensions between accepting crucial foreign assistance and protecting local interests in an ever more data-driven world.

MB
The writer

Matthew Braun

Maya Chen is a music journalist and critic with a passion for indie rock and electronic music, based in Toronto.

Spin Online

Type to search articles.